One prescription drug is keeping some addicts from dying. So why isn’t it more widespread? A story of regulation, stigma, and the potentially fatal faith in abstinence.
Oct 9
690. It’s Show Business, Baby!
Podcasting started as a niche-nerd pursuit. Now it’s a $9 billion industry. Is that a lot? The strange economics of this thing we do. SOURCES:Jim Bankoff, chairman and C.E.O. of Vox Media.Ben Davis, head of digital at WME.Will Page, former chief economist at Spotify and author of ... Show More
1h 1m
Oct 2
689. Here’s Why Your Hamburger Just Got So Pricey
An economist calls America’s beef industry a “miracle.” An antitrust scholar calls it “broken.” Maybe they’re both right? SOURCES:Austin Frerick, agriculture antitrust expert, fellow at Yale University, author of Barons: Money, Power, and the Corruption of America's Food Industry ... Show More
49m 25s
Sep 25
688. When Is a Bet Not a Bet?
That’s the question at the heart of a battle between Kalshi and state gambling regulators. As prediction markets boom, there are other questions, too — about insider trading, market manipulation, and whether the public has turned against them. (Part two of a two-part series.) SOU ... Show More
50m 32s
Jan 2024
What to know about opioids
There have been drastic changes made in the regulation of opioids for medical treatment in the past few decades. However, with advent of fentanyl and carfentanil addiction, overdose-related death continues to increase. In this episode, our guests discuss continued regulation of o ... Show More
26m 12s
Mar 2019
#149 — The Problem of Addiction
Sam Harris speaks with Sally Satel about addiction. They discuss whether addiction should be considered a disease, the opiate epidemic in the U.S., the unique danger of fentanyl, the politicization of medicine, PTSD, and other topics. If the Making Sense podcast logo in your play ... Show More
40m 40s